<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04134052</url>
  </required_header>
  <id_info>
    <org_study_id>090129</org_study_id>
    <nct_id>NCT04134052</nct_id>
  </id_info>
  <brief_title>Ketamine vs Midazolam on Cognitive Function in Elderly in Elective Surgery Three-Months Postoperatively (ketaminvsMDZ)</brief_title>
  <acronym>ketaminvsMDZ</acronym>
  <official_title>Effect of Regional Anesthesia and Sedation With Ketamine Versus Regional Anesthesia and Sedation With Midazolam in Cognitive Function in Patients Over 60 Years of Age in Elective Surgery at 3 Months of Postoperative Follow-up</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad de Colima</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Instituto Mexicano del Seguro Social</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universidad de Colima</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Deterioration of posoperative cognitive function (DCPO) is an intermediate state between
      normal cognitive aging and dementia, defined as a cognitive alteration greater than expected
      for the patient's age and educational level, but which doesn`t interfere with the activities
      of daily life, in its evolution it can lead to dementia or it can present reversal of the
      deterioration with return to a normal cognitive state, or a stabilization with permanence in
      a state of moderate alteration. In general, higher cognitive function can be affected by
      organic or functional problems, anesthetic-surgical, diseases associated with the elderly and
      / or chronic-degenerative comorbidities. Older patients who undergo regional anesthesia have
      special interest, the adverse cardiovascular effects, or prolonged sedation due to a
      pharmacokinetics that is altered by age, call special attention to reduce complications in
      the postoperative period. In 2010 at the Siglo XXI Hospital in Mexico City, the 68-year-old
      population attended was 30% of those with postoperative cognitive dysfunction 26% a week, and
      10% persistence at 3 months. The DSM V recommends a neuropsychiatric, psychological and
      cognitive evaluation of the patient in the postoperative period, through tests such as the
      Mini Mental State Examination. sub-anesthetic doses of ketamine have been recently proposed
      to reduce the postoperative markers of inflammation, pain and opioids, in addition to having
      an antidepressant effect. There is a pharmacological rationale for using ketamine as a
      preventative measure against postoperative delirium based on its N-methyl-D-aspartate (NMDA)
      antagonism, It has the potential to protect against such neurological injury.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Randomized double blind clinical trial. Male and female patients 60-90 years of age scheduled
      in elective surgery under regional anesthesia and sedation.

      The researchers will be double blind and the data analyzer will ignore the drug used ( it it
      should be midazolam or ketamine in an intravenous infusion). The principal investigator will
      limit himself to collecting the questionnaires and following up to 3 months. Simple finite
      randomization in two groups, will be done through envelopes.

      The pre-surgical, post-surgical Mini Mental questionnaire will be applied on the first day, 1
      month and 3 months. During the trans-anesthetic, hemodynamic variables and anesthetic depth
      index measurements will be taken, surgical time, estimated bleeding, use of other adjuvant
      medications, type of surgery and comorbidities will be taken as intervening variables.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2019</start_date>
  <completion_date type="Anticipated">October 20, 2020</completion_date>
  <primary_completion_date type="Anticipated">July 4, 2020</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Simple finite randomization will be performed. The anesthesiologist will choose an envelope with an assigned folio divided into two groups 1) intravenous infusion midazolam and 2) intravenous infusion ketamine, For sedation, regional anesthesia will be applied and hemodynamic variables, administered drugs, type of surgery, surgery time and transoperative bleeding will be recorded, after that, the cognitive evolution will be evaluated with the minimental examination at 3 months postoperatively</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>the participant, the researcher and the outcomes assesor don't know the drug used for sedation.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>cognitive function at baseline</measure>
    <time_frame>It takes 30 minutes before the preparation of the surgery</time_frame>
    <description>the mini mental examination test will be done at baseline for the diagnostic</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change the cognitive function #1</measure>
    <time_frame>It Will be done at the hospital after one day of recovery</time_frame>
    <description>The minimental examination test Will be done after one day of the anesthesic procedure.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change the cognitive function #2</measure>
    <time_frame>It Will be done at the patient home</time_frame>
    <description>The minimental examination test Will be done after one month of the anesthesic procedure.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change the cognitive function#3</measure>
    <time_frame>It Will be done at the patient home three months after the surgery</time_frame>
    <description>The minimental examination test Will be done after three months of the anesthesic procedure.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Cognitive Dysfunction</condition>
  <arm_group>
    <arm_group_label>ketamine sedation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sedation will be performed with ketamine dose 5-20mcg / kg / min in infusion with 100 ml Na Cl solution 0.9% during surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>midazolam sedation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Sedation will be performed with midazolam dose 5 - 35mcg / kg / hr in infusion with 100 ml Na Cl solution 0.9% during surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ketamine sedation versus midazolam sedation</intervention_name>
    <description>Sedation with ketamine 5-20 mcg / kg / hr in infusion in 100ml Na Cl solution 0.9% during surgery and the second midazolam group 5 mcg- 35 mcg / kg / hr in infusion in 100ml Na Cl solution 0.9% will be administered during surgery</description>
    <arm_group_label>ketamine sedation</arm_group_label>
    <arm_group_label>midazolam sedation</arm_group_label>
    <other_name>ketamine sedation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 60-90 years,

          -  complete primary,

          -  ASA I-II,

          -  scheduled for non-urgent surgery,

          -  to whom regional anesthesia and sedation are applied

          -  sign the informed consent

          -  Able to answer the brief examination of the mental state (MMSE ) preliminary with more
             than 24 points

        Exclusion Criteria:

          -  not able to respond to MMSE, deaf-mute, blindness,

          -  history of surgery the last 6 months,

          -  use of pacemakers,

          -  allergy to anesthetics,

          -  use of psychiatric medication, or drugs,

          -  diagnosed neurological disease (cerebrovascular disease, dementia, seizures) ,

          -  surgery scheduled for prostate resection, or reduction of hip fractures
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Oscar-Alberto Newton-Sanchez, Phd</last_name>
    <role>Study Director</role>
    <affiliation>Universidad de Colima</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fabian Rojas-Larios, Phd</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidad de Colima</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>karina Espinoza-Mejia, Msc</last_name>
    <phone>52-1 312-1164758</phone>
    <email>kespinoza2@ucol.mx</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Fabian Rojas-Larios, Phd</last_name>
    <phone>52-1 312 1206804</phone>
    <email>frojas@ucol.mx</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mexican Social Security Institute. General Hospital of Zone 1 Villa de Alvarez</name>
      <address>
        <city>Colima</city>
        <zip>28984</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>karina Espinoza-Mejia, Msc</last_name>
      <phone>52 1 312 11 64758</phone>
      <email>kespinoza2@ucol.mx</email>
    </contact>
    <contact_backup>
      <last_name>Fabian Rojas-Larios, Phd</last_name>
      <phone>52 1 312 12 06804</phone>
      <email>frojas@ucol.mx</email>
    </contact_backup>
    <investigator>
      <last_name>Jose Guzman-Esquivel, Phd</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <results_reference>
    <citation>Hogue CW, Grafman J. Aligning nomenclature for cognitive changes associated with anaesthesia and surgery with broader diagnostic classifications of non-surgical populations: a needed first step. Br J Anaesth. 2018 Nov;121(5):991-993. doi: 10.1016/j.bja.2017.12.029. Epub 2018 Jan 17.</citation>
    <PMID>30336869</PMID>
  </results_reference>
  <results_reference>
    <citation>Evered L, Silbert B, Knopman DS, Scott DA, DeKosky ST, Rasmussen LS, Oh ES, Crosby G, Berger M, Eckenhoff RG; Nomenclature Consensus Working Group. Recommendations for the nomenclature of cognitive change associated with anaesthesia and surgery-2018. Br J Anaesth. 2018 Nov;121(5):1005-1012. doi: 10.1016/j.bja.2017.11.087. Epub 2018 Jun 15. Review.</citation>
    <PMID>30336844</PMID>
  </results_reference>
  <results_reference>
    <citation>Shoair OA, Grasso Ii MP, Lahaye LA, Daniel R, Biddle CJ, Slattum PW. Incidence and risk factors for postoperative cognitive dysfunction in older adults undergoing major noncardiac surgery: A prospective study. J Anaesthesiol Clin Pharmacol. 2015 Jan-Mar;31(1):30-6. doi: 10.4103/0970-9185.150530.</citation>
    <PMID>25788770</PMID>
  </results_reference>
  <results_reference>
    <citation>Li L, Vlisides PE. Ketamine: 50 Years of Modulating the Mind. Front Hum Neurosci. 2016 Nov 29;10:612. eCollection 2016. Review.</citation>
    <PMID>27965560</PMID>
  </results_reference>
  <results_reference>
    <citation>Paredes S, Cortínez L, Contreras V, Silbert B. Post-operative cognitive dysfunction at 3 months in adults after non-cardiac surgery: a qualitative systematic review. Acta Anaesthesiol Scand. 2016 Sep;60(8):1043-58. doi: 10.1111/aas.12724. Epub 2016 Mar 29. Review.</citation>
    <PMID>27027720</PMID>
  </results_reference>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>October 5, 2019</study_first_submitted>
  <study_first_submitted_qc>October 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 21, 2019</study_first_posted>
  <last_update_submitted>June 2, 2020</last_update_submitted>
  <last_update_submitted_qc>June 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad de Colima</investigator_affiliation>
    <investigator_full_name>Pedro Julian Flores Moreno</investigator_full_name>
    <investigator_title>Principal investigator, master of medical sciences</investigator_title>
  </responsible_party>
  <keyword>ketamine</keyword>
  <keyword>midazolam</keyword>
  <keyword>cognitive dysfunction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Midazolam</mesh_term>
    <mesh_term>Ketamine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

